Clinical TrialsSearch results
Number of results: 319
Other
- Phase2/3 Study of OTS102 in Combination With Gemcitabine in Patients With Unresectable Advanced Pancreatic Cancer and Recurrent Pancreatic Cancer(PEGASUS-PC Study)
- Unresectable Advanced and Recurrent Pancreatic Cancer
- OncoTherapy Science, Inc.
- 2009-01-27
Other
- PhaseIII study of gefitinib versus cisplatin plus docetaxel in patients with non-small cell lung cancer with EGFR mutation
- non small cell lung cancer
- West Japan Oncology Group
- 2006-12-11
Other
- Post-marketing study of cilostazol: Study to Confirm Efficacy in Preventing Recurrent Cerebral Infarction in Comparison with Aspirin
- Patients with cerebral infarction (excluding cardiogenic cerebral embolism)
- Otsuka Pharmaceutical Co., Ltd.
- 2005-09-13
Other
- Prednisolone therapy of the first episode of idopatic nephrotic syndrome in children: A Multi-center randomized controlled trial
- Idiopatic nephrotic syndrome in children
- Japanese Study Group of Kidney Disease in Children
- 2007-09-01
Other
- preoperative combined chemothrapy with docetaxel, cisplatin and S-1 in local advanced gastric cancer; multicentric phase II study
- local advanced gastric cancer (excluding T3-4, bulky N2 & N3 and giant type3 & type 4)
- Society for the study of DCS therapy
- 2009-07-01
Other
- Preventive effect of shakuyaku-kanzo-to on neurotoxicity of FOLFOX plus bevacizumab for patients with metastatic colorectal cancer: a prospective phase II study
- Colorectal Cancer
- University of Toyama
- 2009-04-06
Other
- Primary Hyperaldosteronism in Japan
- hypertension
- National Hospital Organization
- 2008-02-01
Other
- Primary prevention of cerebrovascular and cardiovascular events with an oral antidiabetic agent in patients with type 2 diabetes at high risk for cerebral infarction
- Type 2 Diabetes
- PROFIT-J Study Steering Committee
- 2007-10-09
Other
- Prospective Ramdomized Trial of Extracranial-intracranial (EC-IC) Bypass Surgery for Adults with Moyamoya Disease with Hemorrhagic Onset
- Moyamoya disease
- JAM Trial executive and steering committee
- 2005-09-13
Other
- Quantification of Epstein-Barr virus DNA in patients undergoing SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- untreated stage IV or relapsed/refractory NK/T-cell lymphoma
- NK-cell Tumor Study Group
- 2007-06-18